CClinicalTrials.gg
CompletedNCT00247871Updated Feb 13, 2025

Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside

An observational study in Nasal Colonization With MRSA Bacteria, sponsored by University of British Columbia. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2025-02-13.

Sponsored by University of British Columbia · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
600
Sex
All
01

Study summary

We plan to compare data from 300 nasal swab in Vancouver's Downtown Eastside taken in 2001 to data obtained in 2005. The nasal carriage rate of MRSA and the specific characteristic of each MRSA found will be analyzed. A limited amount of associated information will be obtained

Read the detailed description

MRSA samples will be characterized by pulse field gel electropheresis. An 9 item questionnaire will be administered.

02

Conditions studied

  • Nasal Colonization With MRSA Bacteria

Keywords

  • MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Vancouver's Downtown Eastside

Inclusion criteria

Patient had a microbiological sample submitted from the emergency department of the study hospital from 2001- 2005 which grew MRSA.

Exclusion criteria

Exclusion Criteria:

05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
600 participants (estimated)
06

Study locations

1 site
  • Vancouver General Hospital
    Vancouver, British Columbia, Canada
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00247871
Lead sponsor
University of British Columbia
Responsible party
Sponsor
First posted
Nov 2, 2005
Start date
Oct 1, 2005
Primary completion
Dec 1, 2005
Completion
Dec 1, 2012
Last update
Feb 13, 2025

Study contacts

Steve Reynolds, MD
principal investigator · University of British Columbia
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion